Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00152620 · ClinicalTrials.gov registry record · NA
Dexamethasone Versus Methylprednisolone for the Treatment of Active Inflammatory Bowel Disease
A NA study, sponsored by University of Chicago.
- Terminated
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT00152620 is a NA study that was terminated before completion, run by University of Chicago. The registered enrollment target is 40 participants.
The verdict
NCT00152620, a NA study, was terminated before completion, sponsored by University of Chicago.
- TERMINATED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The aim of this therapeutic trial is to compare the response of subjects with active IBD to daily intravenous dexamethasone versus the response to daily intravenous methylprednisolone.
Interventions
- DRUG Dexamethasone
- DRUG Methylprednisolone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2004-06 |
| Est. Completion | 2007-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00152620
The ClinicalTrials.gov registry entry for NCT00152620 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Dexamethasone is the first listed.
NCT00152620 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00152620 about?
NCT00152620 is a clinical study titled "Dexamethasone Versus Methylprednisolone for the Treatment of Active Inflammatory Bowel Disease". The aim of this therapeutic trial is to compare the response of subjects with active IBD to daily intravenous dexamethasone versus the response to daily intravenous methylprednisolone.
What is the current status of trial NCT00152620?
This trial is currently terminated. It is a NA study. The enrollment target is 40 participants. The study started on 2004-06. Estimated completion is 2007-05.
What interventions are being tested in trial NCT00152620?
The interventions under investigation include: Dexamethasone (DRUG), Methylprednisolone (DRUG).
Who is sponsoring clinical trial NCT00152620?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.